Search - tctmd.com

Displaying 101 - 120 of 203

Sort: Relevancy | Date

Presentation TCT 2023

TAVR vs SAVR in Low Gradient AS: Evidence Updates

Presenter: Marie-Annick Clavel

October 24, 2023

Presentation TVT 2023

Point: SAVR

Presenter: Keith Allen

June 09, 2023

Presentation TVT 2023

Position 1: SAVR With Root Enlargement

Presenter: Bo Yang

June 08, 2023

Presentation TVT 2023

Ascending Aorta Dilation & TAVR vs SAVR: When Should it Matter?

Presenter: Katherine Harrington

June 08, 2023

Presentation TVT 2023

Results From TAVR Explanation and Redo SAVR are Important Considerations: Updates and Evidence Gaps

Presenter: Basel Ramlawi

June 08, 2023

Presentation TVT 2023

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Presenter: Danny Dvir

June 08, 2023

Presentation TCT 2022

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Presenter: Michael Reardon

September 19, 2022

Presentation TCT 2022

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

Presenter: Evelio Rodriguez

September 18, 2022

Presentation TCT 2022

TCT 322: National Trends in TAVR and SAVR for Patients with Severe Isolated Aortic Stenosis

Presenter: Toishi Sharma

September 17, 2022

Presentation TCT 2022

TAVR vs SAVR – Case-based Risk Discussion, What Do I Need to Know?: Case-based Lifelong Management of Aortic Stenosis

Presenter: Michael Querijero

September 16, 2022

Presentation TVT 2022

Interpreting TAVR and SAVR PPM Studies: Effects on Clinical Outcomes and Practice?

Presenter: Howard C. Herrmann

June 09, 2022

Presentation TVT 2022

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Presenter: Janarthanan Sathananthan

June 08, 2022

Presentation Miami Valves 2022

Catheter Based Treatment of Structural Heart Disease Year in Review 2022

Presenter: Eduardo de Marchena

February 03, 2022

Presentation Miami Valves 2022

Case: 2D-echocardiogram

Presenter: Pablo Rengifo-Moreno

February 03, 2022

Presentation TCT 2021

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

Presenter: David Wood

November 06, 2021

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

Presentation TCT 2021

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Presenter: Nicolas Van Mieghem

November 05, 2021

Presentation TCT 2021

Case Presentation: 75-Year-Old With Severe AS And Proximal LAD Stenosis - TAVI Alone, TAVI Plus PCI or SAVR Plus CABG?

Presenter: Yousif Ahmad

November 04, 2021

Presentation TCT 2021

Case Presentation: 65-Year-Old With Severe AS And Bicuspid Valve - SAVR or TAVI?

Presenter: Karim Al-Azizi

November 04, 2021

Presentation TCT 2021

Bioprosthetic Valve Failure: Redo SAVR or ViV TAVR?

Presenter: Kendra Grubb

November 04, 2021

Advertisement

TAVR vs SAVR in Low Gradient AS: Evidence Updates

Point: SAVR

Position 1: SAVR With Root Enlargement

Ascending Aorta Dilation & TAVR vs SAVR: When Should it Matter?

Results From TAVR Explanation and Redo SAVR are Important Considerations: Updates and Evidence Gaps

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

TCT 322: National Trends in TAVR and SAVR for Patients with Severe Isolated Aortic Stenosis

TAVR vs SAVR – Case-based Risk Discussion, What Do I Need to Know?: Case-based Lifelong Management of Aortic Stenosis

Interpreting TAVR and SAVR PPM Studies: Effects on Clinical Outcomes and Practice?

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Catheter Based Treatment of Structural Heart Disease Year in Review 2022

Case: 2D-echocardiogram

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Case Presentation: 75-Year-Old With Severe AS And Proximal LAD Stenosis - TAVI Alone, TAVI Plus PCI or SAVR Plus CABG?

Case Presentation: 65-Year-Old With Severe AS And Bicuspid Valve - SAVR or TAVI?

Bioprosthetic Valve Failure: Redo SAVR or ViV TAVR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content